Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001780088-25-000006

CHIEF MEDICAL OFFICER sold 5,358 shares at an average $31.19 ($167,115)

  • CHIEF MEDICAL OFFICER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ticho Barry · CHIEF MEDICAL OFFICER

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-03 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 25,156 D
2025-12-04 Sale : show line 2 in the form 10b5-1 −1,373 $30.76 $42,238 23,783 D
2025-12-04 Sale : show line 3 in the form 10b5-1 −323 $31.32 $10,115 23,460 D
2025-12-05 Sale : show line 4 in the form 10b5-1 −1,673 $31.33 $52,416 21,787 D
2025-12-05 Sale : show line 5 in the form 10b5-1 −1,989 $31.35 $62,346 19,798 D
Open-market sales · 5,358 sh · avg $31.19 · $167,115

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-03 Exercise or conversion : show line 6 in the form 10b5-1 Performance Stock Units −10,000 0 D
Loading xslF345X05/form4-12062025_011222.xml…